{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:52:03Z","timestamp":1791478323844,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd003833.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000}}],"reference-count":86,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003833.pub5","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T09:01:21Z","timestamp":1730192481000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Omega-3 fatty acids for intermittent claudication"],"prefix":"10.1002","volume":"2024","author":[{"given":"Mina","family":"Mohammady","sequence":"additional","affiliation":[{"name":"Community Health Research Center; Isfahan (Khorasgan) Branch, Islamic Azad University; Isfahan Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Brown","sequence":"additional","affiliation":[{"name":"School of Health; Leeds Beckett University; Leeds UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Radmehr","sequence":"additional","affiliation":[{"name":"Community Health Research Center; Isfahan (Khorasgan) Branch, Islamic Azad University; Isfahan Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Shamsoddin","sequence":"additional","affiliation":[{"name":"Cochrane Iran Associate Centre; National Institute for Medical Research Development (NIMAD); Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Janani","sequence":"additional","affiliation":[{"name":"Imperial Clinical Trials Unit (ICTU), School of Public Health; Imperial College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD003833.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/jn\/135.6.1393","article-title":"Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease","volume":"135","author":"Carrero","year":"2005","journal-title":"Journal of Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD003833.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0003-3170(06)74946-X","article-title":"Study of the clinical and analytical repercussions of a nutritional intervention in non-hospitalised patients with intermittent claudication. A controlled randomised study","volume":"58","author":"Carrero","year":"2006","journal-title":"Angiologia"},{"issue":"12","key":"10.1002\/14651858.CD003833.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.nutres.2006.09.024","article-title":"Simvastatin and supplementation with omega-3 polyunsaturated fatty acids and vitamins improves claudication distance in a randomized PILOT study in patients with peripheral vascular disease","volume":"26","author":"Carrero","year":"2006","journal-title":"Nutrition Research (New York, N.Y.)"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0004|cit4","unstructured":"Conway K Dillon M Evans J Howells-Jones R Price P Harding KG A double-blinded, randomised study to determine the effect of omega-3-marine triglycerides on intermittent claudication Yearbook 2005, The Vascular Society of Great Britain & Ireland 2005 Abstract 86"},{"issue":"4","key":"10.1002\/14651858.CD003833.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3945\/jn.114.204594","article-title":"Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease","volume":"145","author":"Edel","year":"2015","journal-title":"Journal of Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD003833.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cct.2011.05.005","article-title":"The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral artery disease: rationale and design of the FLAX-PAD randomized controlled trial","volume":"32","author":"Leyva","year":"2011","journal-title":"Contemporary Clinical Trials"},{"issue":"6","key":"10.1002\/14651858.CD003833.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1139\/cjpp-2018-0280","article-title":"The effects of dietary flaxseed on cardiac arrhythmias and claudication in patients with peripheral arterial disease","volume":"97","author":"Rodriguez-Leyva","year":"2018","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD003833.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/HYPERTENSIONAHA.113.02094","article-title":"Potent antihypertensive action of dietary flaxseed in hypertensive patients","volume":"62","author":"Rodriguez-Leyva","year":"2013","journal-title":"Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD003833.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0002-9610(05)81012-8","article-title":"Fish oil supplementation in patients with stable claudication","volume":"160","author":"Gans","year":"1990","journal-title":"American Journal of Surgery"},{"issue":"6","key":"10.1002\/14651858.CD003833.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1017\/S0007114519001582","article-title":"Effects of n-3 PUFA on endothelial function in patients with peripheral arterial disease: a randomised, placebo-controlled, double-blind trial","volume":"122","author":"Hammer","year":"2019","journal-title":"British Journal of Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD003833.pub5-BIB0011|cit11","first-page":"Abstract P18","article-title":"Randomised controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral vascular disease","volume":"57","author":"Leng","year":"1997","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"6","key":"10.1002\/14651858.CD003833.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0261-5614(98)80318-X","article-title":"Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease","volume":"17","author":"Leng","year":"1998","journal-title":"Clinical Nutrition (Edinburgh, Scotland)"},{"issue":"2","key":"10.1002\/14651858.CD003833.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.atherosclerosis.2011.12.041","article-title":"Effect of omega-3 fatty acid supplementation on markers of platelet and endothelial function in patients with peripheral arterial disease","volume":"221","author":"Mackay","year":"2012","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1002\/14651858.CD003833.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0026-0495(92)90286-J","article-title":"Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation","volume":"41","author":"Mori","year":"1992","journal-title":"Metabolism: Clinical and Experimental"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jss.2016.11.011","article-title":"Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease","volume":"210","author":"Drudi","year":"2017","journal-title":"Journal of Surgical Research"},{"issue":"5","key":"10.1002\/14651858.CD003833.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1358863X13503695","article-title":"N-3 polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial","volume":"18","author":"Grenon","year":"2013","journal-title":"Vascular Medicine (London, England)"},{"issue":"8","key":"10.1002\/14651858.CD003833.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.115.002034","article-title":"Short-term, high-dose fish oil supplementation increases the production of omega-3 fatty acid-derived mediators in patients with peripheral artery disease (the OMEGA-PAD I trial)","volume":"4","author":"Grenon","year":"2015","journal-title":"Journal of the American Heart Association"},{"issue":"5","key":"10.1002\/14651858.CD003833.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jacl.2017.06.011","article-title":"Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements","volume":"11","author":"Schaller","year":"2017","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jss.2019.01.038","article-title":"Fish oil increases specialized pro-resolving lipid mediators in PAD (the OMEGA-PAD II trial)","volume":"238","author":"Ramirez","year":"2019","journal-title":"Journal of Surgical Research"},{"issue":"3","key":"10.1002\/14651858.CD003833.pub5-BIB0020|cit20","first-page":"306","article-title":"Three months of fish oil supplementation increases specialized pro-resolving lipid mediators in patients with peripheral artery disease (The OMEGA-PAD II Trial)","volume":"23","author":"Ramirez","year":"2018","journal-title":"Vascular Medicine (London, England)"},{"issue":"6","key":"10.1002\/14651858.CD003833.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/dom.13674","article-title":"Effects of basal insulin glargine and omega-3 on lower limb arterial disease outcome in patients with dysglycaemia: ananalysis of the outcome reduction with an initial glargine Intervention (ORIGIN) trial","volume":"21","author":"Dagenais","year":"2019","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD003833.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"ORIGIN trial investigators","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003833.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1203859","article-title":"N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia","volume":"367","author":"ORIGIN trial investigators","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003833.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ahj.2007.09.009","article-title":"Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)","volume":"155","author":"ORIGIN trial investigators","year":"2008","journal-title":"American Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD003833.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clnu.2007.11.007","article-title":"Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function","volume":"27","author":"Schiano","year":"2008","journal-title":"Clinical Nutrition (Edinburgh, Scotland)"},{"issue":"2","key":"10.1002\/14651858.CD003833.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.artres.2008.02.001","article-title":"Canola oil decreases cholesterol and improves endothelial function in patients with peripheral arterial occlusive disease - a pilot study","volume":"2","author":"Stricker","year":"2008","journal-title":"Artery Research"},{"issue":"6417","key":"10.1002\/14651858.CD003833.pub5-BIB0027|cit27","first-page":"592","article-title":"Beneficial effect of fish oil on blood viscosity in peripheral vascular disease","volume":"288","author":"Woodcock","year":"1984","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1002\/14651858.CD003833.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-0038-1650285","article-title":"Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease","volume":"75","author":"Berrettini","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD003833.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/HYPERTENSIONAHA.114.03179","article-title":"Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an a-linolenic acid-induced inhibition of soluble epoxide hydrolase","volume":"64","author":"Caligiuri","year":"2014","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0030|cit30","unstructured":"The effect of fish oil on red blood cell function and walking distance in patients with arterial occlusion in the legs clinicaltrialsregister.eu\/ctr-search\/trial\/2013-004342-42\/NL"},{"issue":"7","key":"10.1002\/14651858.CD003833.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1253\/circj.CJ-09-0520","article-title":"Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral arterial disease","volume":"74","author":"Ishikawa","year":"2010","journal-title":"Circulation Journal"},{"issue":"6","key":"10.1002\/14651858.CD003833.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.plefa.2007.04.003","article-title":"Fish oil induced increase in walking distance, but not ankle brachial pressure index, in peripheral arterial disease is dependent on both body mass index and inflammatory genotype","volume":"76","author":"Madden","year":"2007","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003833.pub5-BIB0033|cit33","first-page":"A28","article-title":"The effect of n-3 fatty acids in intermittent claudication","volume":"28","author":"Moller","year":"1998","journal-title":"European Journal of Clinical Investigation"},{"issue":"51","key":"10.1002\/14651858.CD003833.pub5-BIB0034|cit34","first-page":"4855","article-title":"Ineffectiveness of naudicelle in intermittent claudication","volume":"81","author":"Olsson","year":"1984","journal-title":"L\u00e4kartidningen"},{"issue":"1","key":"10.1002\/14651858.CD003833.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S0007114599001099","article-title":"Olive oil- and fish oil-enriched diets modify plasma lipids and susceptibility of LDL to oxidative modification in free-living male patients with peripheral vascular disease: the Spanish Nutrition Study","volume":"82","author":"Ramirez-Tortosa","year":"1999","journal-title":"British Journal of Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD003833.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/jama.2013.280618","article-title":"Association of Mediterranean diet with peripheral artery disease: the PREDIMED randomized trial","volume":"311","author":"Ruiz-Canela","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0037|cit37","first-page":"117","article-title":"Randomized controlled trial to evaluate the effect of canola oil on blood vessel function in peripheral arterial disease: rationale and design of the Canola-PAD Study","volume":"6","author":"Enns","year":"2014","journal-title":"Open Access Journal of Clinical Trials"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0038|cit38","volume-title":"Role of Dietary Fatty Acids from Plant-Based Oils in Metabolic and Vascular Disease [Thesis]","author":"Enns","year":"2012"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0039|cit39","unstructured":"Egg study with peripheral arterial disease clinicaltrials.gov\/ct2\/show\/NCT01256320"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0040|cit40","unstructured":"The use of fish oil to reduce inflammation caused by a peripheral vascular intervention clinicaltrials.gov\/ct2\/show\/NCT02096757"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0041|cit41","unstructured":"The effects of fish oil supplements during supervised exercise therapy in patients with intermittent claudication (FISHTIC) clinicaltrials.gov\/ct2\/show\/NCT02152930"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0042|cit42","unstructured":"The efficacy of EPA on the clinical outcome in patients with arteriosclerosis obliterans undergoing endovascular treatment: prospective study https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000030553"},{"issue":"3","key":"10.1002\/14651858.CD003833.pub5-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003177.pub5","article-title":"Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease","author":"Abdelhamid","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003833.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/09537104.2017.1420154","article-title":"In vivo modeling of docosahexaenoic acid and eicosapentaenoic acid-mediated inhibition of both platelet function and accumulation in arterial thrombi","volume":"30","author":"Adili","year":"2019","journal-title":"Platelets"},{"issue":"8","key":"10.1002\/14651858.CD003833.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/ATVBAHA.120.314595","article-title":"Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease","volume":"40","author":"Barnes","year":"2020","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0046|cit46","volume-title":"Andreoli and Carpenter's Cecil Essentials of Medicine","author":"Benjamin","year":"2016"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/519830","article-title":"Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties \u2013 ready for use in the stroke clinic?","volume":"2015","author":"Blondeau","year":"2015","journal-title":"BioMed Research International"},{"issue":"10","key":"10.1002\/14651858.CD003833.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.amjmed.2019.04.043","article-title":"Peripheral artery disease: past, present, and future","volume":"132","author":"Campia","year":"2019","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0049|cit49","unstructured":"Covidence Veritas Health Innovation 2024"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0050|cit50","unstructured":"Columbus healthier eggs www.columbuseggs.com"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00018-002-8439-1","article-title":"Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action","volume":"59","author":"Demaison","year":"2002","journal-title":"Cellular and Molecular Life Sciences CMLS"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2261-14-70","article-title":"The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis","volume":"14","author":"Enns","year":"2014","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0053|cit53","unstructured":"The Fish Foundation Omega-3 www.fish-foundation.org.uk\/Omega-3.htm"},{"issue":"3","key":"10.1002\/14651858.CD003833.pub5-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"156\u2013170","DOI":"10.1038\/nrcardio.2016.179","article-title":"Peripheral artery disease: epidemiology and global perspectives","volume":"14","author":"Fowkes","year":"2017","journal-title":"Nature Reviews Cardiology"},{"issue":"102","key":"10.1002\/14651858.CD003833.pub5-BIB0055|cit55","first-page":"1","article-title":"ESVM guideline on peripheral arterial disease","volume":"48","author":"Frank","year":"2019","journal-title":"VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases"},{"issue":"12","key":"10.1002\/14651858.CD003833.pub5-BIB0056|cit56","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0057|cit57","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2024"},{"issue":"3","key":"10.1002\/14651858.CD003833.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1253\/circj.CJ-16-1286","article-title":"Pathophysiology of intermittent claudication in peripheral artery disease","volume":"81","author":"Hamburg","year":"2017","journal-title":"Circulation Journal"},{"issue":"4","key":"10.1002\/14651858.CD003833.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0034-1393976","article-title":"Overview of classification systems in peripheral artery disease","volume":"31","author":"Hardman","year":"2014","journal-title":"Seminars in Interventional Radiology"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0060|cit60","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook."},{"issue":"11","key":"10.1002\/14651858.CD003833.pub5-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011094.pub3","article-title":"Omega-6 fats for the primary and secondary prevention of cardiovascular disease","author":"Hooper","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003833.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/ijms21041362","article-title":"Marine omega-3 (N-3) fatty acids for cardiovascular health: an update for 2020","volume":"21","author":"Innes","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1002\/14651858.CD003833.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/intimm\/dxz001","article-title":"Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis","volume":"31","author":"Ishihara","year":"2019","journal-title":"International Immunology"},{"issue":"9","key":"10.1002\/14651858.CD003833.pub5-BIB0064|cit64","first-page":"186","article-title":"Claudication: a teachable moment or missed opportunity","volume":"4","author":"Jindeel","year":"2017","journal-title":"Clinical Medical Reviews Open Access and Case Reports"},{"issue":"52","key":"10.1002\/14651858.CD003833.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcn\/52.1.1","article-title":"Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms","volume":"1","author":"Kinsella","year":"1990","journal-title":"American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD003833.pub5-BIB0066|cit66","first-page":"1","article-title":"Peripheral arterial disease","volume":"25","author":"Kirby","year":"2023","journal-title":"Diabetes & Primary Care"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0067|cit67","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated October 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD003833.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/ATVBAHA.119.313286","article-title":"Emerging mechanisms of cardiovascular protection for the omega-3 fatty acid eicosapentaenoic acid","volume":"40","author":"Mason","year":"2020","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0069|cit69","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated October 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD003833.pub5-BIB0070|cit70","first-page":"138","article-title":"Intention to treat analysis in randomized clinical trials: a review","volume":"23","author":"Mohammady","year":"2017","journal-title":"Hayat"},{"issue":"1","key":"10.1002\/14651858.CD003833.pub5-BIB0071|cit71","first-page":"6","article-title":"Omega-3 supplements and cardiovascular diseases","volume":"13","author":"Mohebi-Nejad","year":"2014","journal-title":"Tanaffos"},{"issue":"20","key":"10.1002\/14651858.CD003833.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 fatty acids and cardiovascular disease effects on risk factors, molecular pathways, and clinical events","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0073|cit73","unstructured":"Omega-3 Information Service Omega-3 essential fatty acids www.clo3.com"},{"issue":"4","key":"10.1002\/14651858.CD003833.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCRESAHA.121.320702","article-title":"Sex differences in peripheral artery disease","volume":"130","author":"Pabon","year":"2022","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0075|cit75","unstructured":"Review Manager The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0076|cit76","unstructured":"Bridging the nutritional gap: omega-3 LC-PUFA food enrichment www.foodprocessing.com\/Media\/MediaManager\/Omega3fattyacidsDSM.pdf"},{"issue":"61","key":"10.1002\/14651858.CD003833.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jacc.2013.01.054","article-title":"Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects","volume":"23","author":"Savji","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jclinepi.2019.12.021","article-title":"GRADE guidelines: 21 part 2. Inconsistency, imprecision, publication bias and other domains for rating the certainty of evidence for test accuracy and presenting it in evidence profiles and summary of findings tables","volume":"122","author":"Sch\u00fcnemann","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0079|cit79","unstructured":"Seven Seas Health Care Pharmaceutical products: Maxepa and Epanoil fish oils www.sseasirl.com\/About\/SpecOil\/specoil.html"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"379\u201381","DOI":"10.1016\/j.atherosclerosis.2018.05.033","article-title":"Update on peripheral artery disease: epidemiology and evidence-based facts","volume":"275","author":"Shu","year":"2018","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1002\/14651858.CD003833.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1002\/14651858.CD003833.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2013.10.014","article-title":"Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel anti-inflammatory effect in adults with metabolic syndrome","volume":"232","author":"Tousoulis","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD003833.pub5-BIB0083|cit83","volume-title":"Cecil Essentials of Medicine","author":"Wing","year":"2021"},{"issue":"7","key":"10.1002\/14651858.CD003833.pub5-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003833.pub4","article-title":"Omega-3 fatty acids for intermittent claudication","author":"Campbell","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003833.pub5-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003833.pub2","article-title":"Omega-3 fatty acids for intermittent claudication","author":"Sommerfield","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003833.pub5-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003833.pub3","article-title":"Omega-3 fatty acids for intermittent claudication","author":"Sommerfield","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:04:45Z","timestamp":1767593085000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003833.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":86,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003833.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]}}}